Pds Biotechnology Corporation (PDSB)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Pds Biotechnology Corporation-Aktie (PDSB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-07-01	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	8.1401	-	9.1058	7.3606	10.18
Operating Income/Loss	-8.1401	-	-9.1058	-7.3606	-10.18
Income/Loss From Continuing Operations Before Tax	4.50% -9.0094	-9.4342	-9.6588	-7.9524	-10.73
Income Tax Expense/Benefit	-	-	-1.1698	-	-
Income/Loss From Continuing Operations After Tax	4.50% -9.0094	-9.4342	-8.489	-7.9524	-10.73
Net Income/Loss	4.50% -9.0094	-9.4342	-8.489	-7.9524	-10.73
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	46.87	-	40.52	0.3448	36.81
Diluted Average Shares	46.87	-	40.52	0.3448	36.81
Basic Earnings Per Share	-0.19	-	-0.21	-0.21	-0.29
Diluted Earnings Per Share	-0.19	-	-0.21	-0.21	-0.29
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-